ASN: Elderly with chronic kidney disease benefit from SGLT2 inhibitors

Sodium-glucose cotransporter 2 (SGLT2) inhibitors show significant benefits for adults aged 80 years and older with chronic kidney disease (CKD), acco…

Continue in Briflio to read, react, comment, and share.